Isoflavones Market size to surpass $28 Bn by 2032

Isoflavones Market size is set to cross USD 28 billion by 2032, according to a new research report by Global Market Insights Inc.
 

The increasing consumption of protein supplements worldwide will complement the isoflavones industry expansion. With the growing focus on health and fitness along with the proliferating gym community, the preference for protein has increased substantially over the past few years. Moreover, the growing disposable incomes across several developed and developing economies have accelerated consumer spending on advanced protein formulations. Europe in particular has experienced notable surge in the demand for plant-based foods, including soy. In January 2023, ACI Group, a U.K.-based distributor, inked a new agreement with Soy Austria, a leading producer of sustainable soy-based GMO-free ingredients to distribute soy-based solutions in Ireland and the U.K.
 

Rising consumption of chickpea isoflavones to treat chronic and gut health problems to augment the industry trends

Isoflavones market size from the chickpea source segment is anticipated to register 5.5% CAGR from 2023 to 2032. Chickpea is one of the richest sources of isoflavones and is widely consumed owing to its health benefits as it assists in blood regulation and reducing the risk of cardiovascular diseases. Chickpeas have emerged as prominent plant-based protein alternatives rich in antioxidants for vegetarians. Several food and health agencies, such as the American Diabetes Association recommend a daily intake of chickpeas to meet the body’s need for dietary fiber. With the rising prevalence of gastrointestinal and digestive disorders, the consumption of chickpea isoflavones is slated to rise notably.
 

Browse key industry insights spread across 300 pages with 377 market data tables and 29 figures & charts from the report, “Isoflavones Market Size By Source [Soy (Food & beverages, Nutraceuticals, Cosmetics), Chickpea (Food & beverages, Nutraceuticals, Cosmetics), Red Clover (Food & beverages, Nutraceuticals, Cosmetics)], & Forecast 2023 – 2032” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/isoflavones-market        
 

Increasing need for food fortification to propel the demand for isoflavones in food & beverages sector

In terms of revenue, the isoflavones market share from food & beverages segment is estimated to exceed USD 6.5 billion by 2032, attributed to the growing demand for fortified and value-added food products. The increasing consumer awareness regarding food labels and ingredients is fostering significant scope for products comprising isoflavones as they prevent the buildup of arterial plaque, further reducing the risk of coronary heart diseases. Furthermore, the growing emphasis on food fortification to curb nutrient and dietary deficiencies is expected to spur the market growth.
 

Expanding geriatric population to fuel the demand for isoflavone ingredients in Europe

Europe isoflavones market will reach USD 6 billion by 2032, due to the burgeoning food processing sector, the growing demand for nutraceuticals, and the surging consumer preference for plant-based supplements. The escalating geriatric population will indicate significant need for value-added food products and supplements. According to data from the Centre for Ageing Better, the geriatric population in England is projected to exceed 13 million in the following decade to account for 22% of the regional population. Furthermore, the demand for isoflavone sources such as soy and red clover will gain substantial momentum across Europe’s booming cosmetics sector for application in creams, moisturizers, and lotions.
 

Production innovations to favor isoflavones industry growth

Major players involved in the isoflavones market include ADM, Medisys Biotech, Guzen Development, Fujicco Co., Ltd, HerboNutra, Frutarom Ltd., SK Bioland, Aushadhi Herbal, Nutra Green Biotechnology Co., Ltd., and Tradichem. These firms are focusing on the integration of innovative technologies to boost their production. For instance, in November 2021, Tradichem announced the development of the Hipering® technology enabled by Piab’s piFLOW®p vacuum conveyor for the miniaturization of active pharma ingredients.